Exact Mass: 308.9781884
Exact Mass Matches: 308.9781884
Found 90 metabolites which its exact mass value is equals to given mass value 308.9781884,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lamivudine-monophosphate
C8H12N3O6PS (309.01844220000004)
Lamivudine-monophosphate is a metabolite of lamivudine. Lamivudine (2,3-dideoxy-3-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. (Wikipedia)
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid is a metabolite of mefloquine. Mefloquine hydrochloride (also known as Lariam or Mefaquin) is an orally administered medication used in the prevention and treatment of malaria. Mefloquine was developed in the 1970s at the United States Department of Defenses Walter Reed Army Institute of Research as a synthetic analogue of quinine. The brand name drug, Lariam, is manufactured by the Swiss company Hoffmann–La Roche. In August 2009, Roche stopped marketing Lariam in the United States. (Wikipedia)
3-oxobrimonidine
3-oxobrimonidine is a metabolite of brimonidine. Brimonidine (bri-MOE-ni-deen, brand names Alphagan and Alphagan-P) is a drug used to treat open-angle glaucoma or ocular hypertension. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. As a treatment for glaucoma, it is usually given in eyedrop form. (Wikipedia)
PRZ_M310
C12H14Cl3NO2 (309.00900740000003)
CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2015
2,8-BIS(TRIFLUROMETHYL)-4-QUINOLINCARBOXYLIC ACID
5-BROMO-2-CHLORO-N-PHENYLBENZAMIDE
C13H9BrClNO (308.95559940000004)
ethyl 6-bromo-8-methyl-4-oxo-1H-quinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
5-(CHLOROMETHYL)-2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOLE
N-(4-Bromophenyl)-4,4,4-trifluoro-3-oxobutanamide
C10H7BrF3NO2 (308.96122180000003)
3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine
2-[(4-BROMOPHENYL)THIO]NICOTINIC ACID
C12H8BrNO2S (308.94590880000004)
METHYL 3-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-2-CARBOXYLATE
2-Bromo-N-(4-chlorophenyl)benzamide
C13H9BrClNO (308.95559940000004)
2-chloro-10-(3-chloropropyl)-10H-phenothiazine
C15H13Cl2NS (309.01457180000006)
4-BROMO-N-(FURAN-2-YLMETHYL)-3-METHOXYBENZAMIDE
C13H12BrNO3 (309.00005020000003)
Ethyl1-(5-bromopyridin-2-yl)-5-methylpyrazole-4-carboxylate
5-Bromo-1-(4-methoxybenzyl)-1H-pyrrole-2-carboxylic acid
C13H12BrNO3 (309.00005020000003)
2,5-Cyclohexadien-1-one,4-[[4-(acetyloxy)phenyl]imino]-2,6-dichloro-
Ethanone,2-chloro-1-(2-chloro-10H-phenothiazin-10-yl)-
ethyl 4-bromo-6-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
2-amino-5-bromo-2-chlorobenzophenone
C13H9BrClNO (308.95559940000004)
3-(3-chlorophenyl)-4-cyano-5-methylsulfanylthiophene-2-carboxylic acid
3-(4-CHLOROPHENYL)-4-CYANO-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
ETHYL5-AMINO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
METHYL 2-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-3-CARBOXYLATE
METHYL 3-AMINO-4-(ISOPROPYLSULFONYL)-5-(METHYLTHIO)THIOPHENE- 2-CARBOXYLATE
[2-(3-bromo-phenyl)-ethyl]-(4-chloro-phenyl)-amine
C14H13BrClN (308.9919828000001)
6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide
ETHYL 5-AMINO-1-(2-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
4-Bromo-N-(4-chlorophenyl)benzamide
C13H9BrClNO (308.95559940000004)
5-chloro-N-(2,4-difluorophenyl)thiophene-2-sulfonamide
3-Chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-ol 5,5-dioxide
ethyl 4-bromo-8-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
4-ISOXAZOLECARBOXYLIC ACID, 5-(4-BROMOPHENYL)-3-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
5-bromo-N-cyclopentyl-2-(trifluoromethyl)pyrimidin-4-amine
4-bromo-N-(tert-butyl)-2-fluorobenzenesulfonamide
C10H13BrFNO2S (308.98343500000004)
5-bromo-n-(2-hydroxyethyl)-2-methoxybenzenesulfonamide
2-(5-bromo-4-oxopentyl)isoindole-1,3-dione
C13H12BrNO3 (309.00005020000003)
4-[(4-CHLOROPHENYL)SULFANYL]-3-NITROBENZENECARBOXYLIC ACID
C13H8ClNO4S (308.98625580000004)
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-BROMOPHENYL)-5-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
Anagrelide hydrochloride monohydrate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent
5-Hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 5-hydroxylation followed by oxidation.
6-Amino-5-[(4-chlorophenyl)sulfonyl]-2-hydroxynicotinonitrile
C12H8ClN3O3S (308.99748880000004)
1-Methyl-3-trifluoromethyl-1H-thieno[2,3-C]pyrazole-5-carboxylic acid (2-mercapto-ethyl)-amide
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]formamide
C12H14Cl3NO2 (309.00900740000003)
N-[(E)-(5-bromothiophen-2-yl)methylideneamino]pyridine-2-carboxamide
C11H8BrN3OS (308.95714180000004)
4-hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 4-hydroxylation followed by oxidation.